Cosmetic Raw Material Skin Whitening Acid Tranexamic CAS 1197-18-8 Tranexamic Acid powder

Antifibrinolytic Action: Inhibition of Plasmin Formation: Tranexamic acid inhibits the activation of plasminogen to plasmin, an enzyme crucial for the breakdown of blood clots. By preventing excessive fibrinolysis, TXA helps maintain the stability of blood clots.

Hemostatic Effects:

Bleeding Control: TXA is widely used in medical settings, especially during surgeries, trauma, and procedures with a risk of significant blood loss. It promotes hemostasis by reducing bleeding and preventing the premature dissolution of blood clots.

Management of Hemorrhagic Conditions:

Menstrual Bleeding: Tranexamic acid is employed to address heavy menstrual bleeding (menorrhagia), providing relief by reducing excessive blood loss during menstrual periods.

Dermatological Applications:

Hyperpigmentation Treatment: In dermatology, TXA has gained popularity for its ability to inhibit melanin synthesis and reduce hyperpigmentation. It is used in topical formulations to address conditions such as melasma and other forms of skin discoloration.

Reduction of Surgical Blood Loss:

Surgical Procedures: Tranexamic acid is often administered before and during certain surgeries to minimize bleeding, making it particularly useful in orthopedic and cardiac procedures.

Traumatic Injuries: TXA is employed in the management of traumatic injuries to control bleeding and improve outcomes in critical care settings.